These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19884797)

  • 21. p53 ubiquitination: Mdm2 and beyond.
    Brooks CL; Gu W
    Mol Cell; 2006 Feb; 21(3):307-15. PubMed ID: 16455486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. USP7 Enforces Heterochromatinization of p53 Target Promoters by Protecting SUV39H1 from MDM2-Mediated Degradation.
    Mungamuri SK; Qiao RF; Yao S; Manfredi JJ; Gu W; Aaronson SA
    Cell Rep; 2016 Mar; 14(11):2528-37. PubMed ID: 26971997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interplay between p53-family, their regulators, and PARPs in DNA repair.
    Emami S
    Clin Res Hepatol Gastroenterol; 2011 Feb; 35(2):98-104. PubMed ID: 21177056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. USP7 controls Chk1 protein stability by direct deubiquitination.
    Alonso-de Vega I; Martín Y; Smits VA
    Cell Cycle; 2014; 13(24):3921-6. PubMed ID: 25483066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The importance of a SNiP of the MDM2 gene to modulate the p53 pathway and the predisposition to cancer].
    Larsen CJ
    Bull Cancer; 2011 Jan; 98(1):10. PubMed ID: 21591298
    [No Abstract]   [Full Text] [Related]  

  • 26. p53 expression and relationship with MDM2 amplification in breast carcinomas.
    Buyukpinarbasili N; Gucin Z; Ersoy YE; İlbak A; Kadioglu H; Muslumanoglu M
    Ann Diagn Pathol; 2016 Apr; 21():29-34. PubMed ID: 27040927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mdmx: a p53 activator?
    Jochemsen AG
    Cell Cycle; 2012 Mar; 11(5):843. PubMed ID: 22356751
    [No Abstract]   [Full Text] [Related]  

  • 28. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
    Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
    Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma.
    Li L; Tao Q; Jin H; van Hasselt A; Poon FF; Wang X; Zeng MS; Jia WH; Zeng YX; Chan AT; Cao Y
    Clin Cancer Res; 2010 Jun; 16(11):2949-58. PubMed ID: 20395212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The deubiquitinating enzyme USP24 is a regulator of the UV damage response.
    Zhang L; Nemzow L; Chen H; Lubin A; Rong X; Sun Z; Harris TK; Gong F
    Cell Rep; 2015 Jan; 10(2):140-7. PubMed ID: 25578727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.
    Okamoto K; Taya Y; Nakagama H
    FEBS Lett; 2009 Sep; 583(17):2710-4. PubMed ID: 19619542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells.
    Hu W; Feng Z; Ma L; Wagner J; Rice JJ; Stolovitzky G; Levine AJ
    Cancer Res; 2007 Mar; 67(6):2757-65. PubMed ID: 17363597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
    Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
    FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The can and can't dos of p53 RNA.
    Candeias MM
    Biochimie; 2011 Nov; 93(11):1962-5. PubMed ID: 21722702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer.
    Agrawal A; Yang J; Murphy RF; Agrawal DK
    Exp Mol Pathol; 2006 Oct; 81(2):115-22. PubMed ID: 16919268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of the p53/MDM2 interplay by HAUSP inhibitors.
    Tavana O; Gu W
    J Mol Cell Biol; 2017 Feb; 9(1):45-52. PubMed ID: 27927749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy.
    Zhou G; Duan Y; Ma G; Wu W; Hu Z; Chen N; Chee Y; Cui J; Samad A; Matsubara JA; Mukai S; D'Amore PA; Lei H
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5361-5367. PubMed ID: 29049737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mdm2-dependent regulation of p53 expression during long-term potentiation.
    Lisachev PD; Pustylnyak VO; Shtark MB
    Bull Exp Biol Med; 2015 Jan; 158(3):333-5. PubMed ID: 25573363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive single nucleotide polymorphism study supports the role of MDM2 in p53-competent chronic lymphocytic leukemia.
    Lucas DM; Byrd JC
    J Clin Oncol; 2008 May; 26(14):2244-5. PubMed ID: 18467712
    [No Abstract]   [Full Text] [Related]  

  • 40. Polymorphic variants in the p53 pathway.
    Murphy ME
    Cell Death Differ; 2006 Jun; 13(6):916-20. PubMed ID: 16557270
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.